CDMRP: Peer Reviewed Prostate Cancer Research Program (PCRP) – Health Disparity Research Award

The Prostate Cancer Research Program funds the Health Disparity Research Award, projects of three (3) years duration for a total of $600,000 in the below topic areas.

• Biomarker Development: Validation and qualification of biomarkers for early detection of clinically relevant disease or for prognosis or prediction and assessment of response to therapies.
• Genetics: Understanding host or tumor genetics and epigenetics responsible for susceptibility, disease progression, and treatment outcomes for clinically relevant prostate cancer.
• Imaging: Development of new anatomic, functional, and molecular imaging approaches for the detection and management of clinically relevant prostate cancer.
• Mechanisms of Resistance and Response: Understanding primary and acquired resistance as well as exceptional response to therapy.
• Survivorship and Palliative Care: Improving the quality of life and well-being of prostate cancer patients and their families.
• Therapy: Identification of targets and pathways, and optimization (including sequencing and combination therapies) of therapeutic modalities, including metastatic prostate cancer.
• Tumor and Microenvironment Biology: Understanding the intrinsic and extrinsic mechanisms contributing to tumor development and the progression of prostate cancer.

http://www.grants.gov/web/grants/view-opportunity.html?oppId=276746